The Q4 EPS scorecard for the S&P 500 members showing a roughly 6% increase from last year indicates a positive trend in this season’s earnings. This week has revealed the strong performance of several top-rated Zacks stocks, offering potential opportunities for investors to explore.
Energy Transfer ET
Energy Transfer, holding a Zacks Rank #1 (Strong Buy), reported Q4 earnings of $0.37 a share on Wednesday, surpassing the Zacks Consensus of $0.29 a share by 27%. Its fourth quarter EPS also grew 8% from a year ago, and estimates for fiscal 2024 and FY25 have seen a 5% and 9% increase respectively over the last 30 days. It’s noteworthy that Energy Transfer’s Zacks Oil and Gas-Production Pipeline-MLB Industry is currently in the top 20% of over 250 Zacks industries.
Blackline BL
Blackline, a Zacks Rank #2 (Buy) company, contributed to the tech sector’s growth by revealing its Q4 earnings that nearly doubled to $0.69 a share, surpassing estimates of $0.55 a share by 25%. Furthermore, Blackline’s gross profit has soared by 11% from the comparative quarter to $118.11 million, indicating strong growth potential.
DaVita DVA
DaVita, a Zacks Rank #2 (Buy) company, continued to demonstrate its appealing growth potential in the medical sector by posting Q4 earnings of $1.87 per share on Tuesday, surpassing estimates of $1.53 a share by 22%. Q4 EPS rose by 68% from $1.11 a share in the prior year, and DaVita has exceeded earnings expectations for the past five quarters, with an impressive average earnings surprise of 35% in its last four quarterly reports.
Key Takeaway
Investors are always on the lookout for stocks of companies that consistently exceed earnings expectations, indicating strong business operations. These top-rated Zacks stocks, after comfortably surpassing their Q4 earnings expectations, stand out as potential opportunities for a bullish trend in the coming weeks.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. This is a timely investment that you can catch while it emerges from its bear market lows.
It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock And 4 Runners Up
DaVita Inc. (DVA) : Free Stock Analysis Report
Energy Transfer LP (ET) : Free Stock Analysis Report
BlackLine (BL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
